Sinco Pharmaceuticals Holdings Limited (HKG:6833)

HKG:6833 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	232.63	308.32	437.92	329.14	326.05	143.77
Cash & Short-Term Investments	232.63	308.32	437.92	329.14	326.05	143.77
Cash Growth	-17.51%	-29.59%	33.05%	0.95%	126.79%	-35.17%
Accounts Receivable	727.07	608.25	540.51	351.27	213.6	578.69
Other Receivables	59.91	73.14	51.88	37.74	10.35	8.52
Receivables	786.98	681.39	592.38	389.01	223.96	587.2
Inventory	274.04	352.53	108.03	89.58	62.76	242.56
Prepaid Expenses	-	-	-	-	1.3	0.81
Restricted Cash	22.11	103.06	220.03	107.85	55.02	-
Other Current Assets	72.53	66.91	74.93	101.82	299.9	31.39
Total Current Assets	1,388	1,512	1,433	1,017	968.98	1,006
Property, Plant & Equipment	364.46	371.36	354.21	315.84	256.26	238.18
Goodwill	66.54	66.54	66.54	66.54	-	-
Other Intangible Assets	49.53	11.81	14.03	15	-	0.02
Long-Term Deferred Tax Assets	5.17	2.42	3.4	3	0.86	0.65
Long-Term Deferred Charges	-	30.14	13.08	-	-	-
Other Long-Term Assets	5.87	5.96	6.14	6.55	6.67	7.48
Total Assets	1,880	2,000	1,891	1,424	1,233	1,252
Accounts Payable	919.56	887.97	866.59	407.99	422.93	700.32
Accrued Expenses	15.37	14.67	17.13	86.11	17.49	127.3
Short-Term Debt	-	340	240	180.81	207.51	77.16
Current Portion of Long-Term Debt	221.62	0.86	0.86	-	0.81	0.83
Current Portion of Leases	4.6	5.14	3.83	3	0.38	0.74
Current Income Taxes Payable	15.15	20.59	26.44	5.44	12.83	22
Current Unearned Revenue	9.86	27.73	40.46	75.43	27.75	27.81
Other Current Liabilities	7.29	34.7	36.73	31.82	35.93	34.65
Total Current Liabilities	1,193	1,332	1,232	790.59	725.64	990.79
Long-Term Debt	-	0.05	0.89	0.92	132.24	3.04
Long-Term Leases	1.68	4.49	5.83	7.69	-	0.37
Long-Term Deferred Tax Liabilities	1.13	1.35	1.8	2.25	-	-
Other Long-Term Liabilities	-	-	22.08	19.08	-	93.42
Total Liabilities	1,196	1,338	1,263	820.52	857.88	1,088
Common Stock	0.16	0.16	0.16	0.16	0.15	0.14
Additional Paid-In Capital	529.48	529.48	529.48	529.48	370.02	293.36
Retained Earnings	153.96	133.24	98.41	74.17	0.48	-135.08
Comprehensive Income & Other	-	-	-	-	4.23	6.92
Total Common Equity	683.6	662.88	628.05	603.81	374.89	165.34
Minority Interest	-	-	-	-	-	-0.91
Shareholders' Equity	683.6	662.88	628.05	603.81	374.89	164.43
Total Liabilities & Equity	1,880	2,000	1,891	1,424	1,233	1,252
Total Debt	227.9	350.54	251.4	192.41	340.95	82.13
Net Cash (Debt)	4.73	-42.22	186.52	136.73	-14.9	61.63
Net Cash Growth	-	-	36.41%	-	-	86.29%
Net Cash Per Share	0.00	-0.02	0.09	0.07	-0.01	0.04
Filing Date Shares Outstanding	2,033	2,033	2,033	2,033	1,873	1,692
Total Common Shares Outstanding	2,033	2,033	2,033	2,033	1,873	1,692
Working Capital	194.84	180.55	201.25	226.82	243.34	14.93
Book Value Per Share	0.34	0.33	0.31	0.30	0.20	0.10
Tangible Book Value	567.53	584.53	547.49	522.28	374.89	165.32
Tangible Book Value Per Share	0.28	0.29	0.27	0.26	0.20	0.10
Land	-	-	-	-	-	175.16
Buildings	-	214.5	196.87	197.31	197.31	-
Machinery	-	58.89	25.98	22.94	20.06	20.03
Construction In Progress	-	68.04	107.3	84.58	33.5	31.24
Leasehold Improvements	-	36.32	13.67	11.19	11.08	10.95

Source: S&P Global Market Intelligence. Standard template. Financial Sources.